MedImmune SWOT Analysis

MedImmune SWOT Analysis

Strengths

Medimmune:partnership with wyeth pharmaceutica Please edit this page to add a description…
Medimmune:hold patent on flumist technology ti Please edit this page to add a description…
Primary advantage with product differentiation (MedImmune) Please edit this page to add a description…

Weaknesses

Medimmune:slow start with only 6 million doses Please edit this page to add a description…
Awaiting FDA approval (MedImmune) Please edit this page to add a description…
Low volume cost is 3x peak capacity cost (MedImmune) Please edit this page to add a description…
Needs to be frozen as opposed to refrigerated (MedImmune) Please edit this page to add a description…

Opportunities

Large population (MedImmune) Please edit this page to add a description…
Inexpensive product (MedImmune) Please edit this page to add a description…
Flu vaccination annually (MedImmune) Please edit this page to add a description…

Threats

Possible low adoption rate (MedImmune) Please edit this page to add a description…
FDA might not approve (MedImmune) Please edit this page to add a description…
3 Rival companies offering substitutes (MedImmune) Please edit this page to add a description…

MedImmune SWOT Analysis Profile

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.